annexure b – directors' remuneration
for the year ended 30 June

 

Directors’ remuneration

The remuneration paid to executive directors while in office of the Company during the year ended 30 June 2018 is analysed as follows:

Director Basic
remuneration
R’000
Retirement/
medical
benefits
R’000
Other
benefits
and costs
R’000
Cash
incentives
R’000
Benefit
arising
from the
exercise of
replacement
rights
R’000
Total
emoluments
R’000
 
AW Dawe 4 843 257 82 7 010 12 192   
NT Madisa 3 301 297 244 4 948 13 273 22 063  
GC McMahon 1 851 240 182 3 024 5 297  
HP Meijer¹ 2 336 286 271 10 510 13 403  
LP Ralphs 10 260 880 1 011 17 492 29 643  
MJ Steyn² 2 738 254 102 2 500 1 782 7 375  
2018 Total 25 329 2 214 1 891 34 974 25 565 89 973  

Certain executive directors serve as non-executive directors of companies outside of the Group. Directors’ fees in this regard are paid to the Group.

For comparative purposes the remuneration paid to executive directors, while in office of the Company during the year ended 30 June 2017, is analysed as follows:

Director Basic
remuneration
R’000
Retirement/
medical
benefits
R’000
Other
benefits
and costs
R’000
Cash
incentives
R’000
Benefit
arising
from the
exercise of
replacement
rights
R’000
Total
emoluments
R’000
 
AW Dawe 4 487 263 76 3 347 8 173   
NT Madisa 3 027 272 89 2 324 5 712  
GC McMahon 1 672 218 154 1 409 4 005 7 458  
HP Meijer¹ 3 237 397 164 2 606 10 934 17 338  
LP Ralphs 9 164 825 912 7 227 91 865 109 993  
2017 Total 21 587 1 975 1 395 16 913 106 804 148 674  

1 Retired 28 February 2018

2 Appointed as Group CFO 1 March 2018. Remuneration for 12 months

The remuneration paid to non-executive directors while in office of the Company during the year ended 30 June 2018 is analysed as follows:

Director Directors’
fees
R’000
2018
As directors
of subsidiary
companies
and other
services
R’000
Total
emoluments
R’000
    2017
Total
R’000
 
DDB Band 718 718     551  
EK Diack 570 508 1 078     1 583  
B Joffe 23 23     4 203  
AK Maditsi 613 613     535  
S Masinga 595 595     582  
RK Mokate 114 597 711      
CWN Molope 371 371      
NG Payne 1 349 875 2 224     2 169  
CWL Phalatse 1 430 1 430     1 350  
T Slabbert 655 655     562  
NW Thomson 148 148      
2018 total 6 586 1 980 8 566     11 535  
2017 total 5 887 5 648 11 535      

Prescribed officers

Due to the nature and structure of the Group and the number of executive directors on the board of the Company, the directors have concluded that there are no prescribed officers of the Company.

Directors’ long-term incentives

Details of the directors’ and officers’ outstanding replacement rights are as follows:

  Replacement rights
at 30 June 2017
    Replacement rights
exercised during
the year
    Replacement rights
lapsed during the
year
    Replacement rights
at 30 June 2018
 
Directors Number Average
price
R
    Number Market
price3
    Number Market
price3
    Number Average
price
R
 
AW Dawe 133 066 267,27             133 066 267,27  
NT Madisa 118 566 266,49     50 783 240,97         67 783 285,60  
GC McMahon 61 250 271,44             61 250 271,44  
P Meijer 115 566 269,29     42 783 247,16     42 017 276,31     30 766 290,49  
MJ Steyn 45 000 260,09     7 500 250,73         37 500 261,96  
  473 448 267,42     101 066 244,32     42 017 276,31     330 365 273,36  
Former company secretary                              
CA Brighton   20 578   262,26       6 539   257,56       14 039   264,44          
  494 026 267,21     107 605 245,72     56 056 273,34     330 365 273,36  

Refer to note 27 of the financial statements for further details.

A share appreciation right (SAR) is a right awarded subject to the appreciation of the Company’s shares.

  SARs at
30 June 2017
    SARs granted
during the year
    SARs lapsed
during the year
    SARs at
30 June 2018
 
Directors Number Average
price
R
    Number Average
price
R
    Number Market
price3
    Number Average
price
R
 
MJ Steyn 40 000 146,61     40 000 158,75         80 000 152,68  
Former company secretary                              
CA Brighton 14 000 146,61         14 000 146,61      
  54 000 146,61     40 000 158,75     14 000 146,61     80 000 152,68  

These SARs are exercisable over the period 1 July 2019 to 31 December 2024. A detailed register of SARs outstanding by tranche is available for inspection at the Company’s register office.

Share-based payment expense

  2018 
R’000 
    2017 
R’000 
 
AW Dawe 4 211     3 687  
NT Madisa 3 602     3 086  
GC McMahon 2 048     1 834  
HP Meijer 2 854     3 710  
LP Ralphs 8 786     3 920  
MJ Steyn 1 756      
  23 257     16 237  

Details of directors’ and officers’ outstanding conditional share plan (CSP)

A conditional award is a conditional right to a share, which is awarded subject to performance and vesting conditions.

Director Balance
at
2017
Number
    New
awards
Number
    Forfeited
Number
    Shares
awarded
Number
    Closing
balance
30 June
2018
Number
 
AW Dawe 28 000     38 000             66 000  
GC McMahon 12 000     15 000             27 000  
LP Ralphs 174 280     112 000             286 280  
NT Madisa 20 000     30 000             50 000  
HP Meijer 22 000                 22 000  
  256 280     195 000             451 280